The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Theraputics Inc (ACRS) | COM | 00461U105 | 4,105 | 634,455 | SH | SOLE | 634,455 | 0 | 0 | ||
Aeglea Biotherapeutics Inc (AGLE) | COM | 00773J103 | 13,309 | 1,691,151 | SH | SOLE | 1,691,151 | 0 | 0 | ||
Atreca Inc (BCEL) | CL A COM | 04965G109 | 6,261 | 387,653 | SH | SOLE | 387,653 | 0 | 0 | ||
AVROBIO, Inc. (AVRO) | COM | 05455M100 | 14,076 | 1,009,779 | SH | SOLE | 1,009,779 | 0 | 0 | ||
BridgeBio Pharma Inc (BBIO) | COM | 10806X102 | 283,687 | 3,989,412 | SH | SOLE | 3,989,412 | 0 | 0 | ||
Eidos Therapeutics, Inc. (EIDIX) | COM | 28249H104 | 147,847 | 1,123,630 | SH | SOLE | 1,123,630 | 0 | 0 | ||
HARMONY BIOSCIENCES HLDGS IN (HRMY) | COM | 413197104 | 30,468 | 842,815 | SH | SOLE | 842,815 | 0 | 0 | ||
Marker Therapeutics, Inc. (MRKR) | COM | 57055L107 | 2,900 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
Nabriva Therapeutics plc (NBRV) | SHS | G63637105 | 462 | 191,028 | SH | SOLE | 191,028 | 0 | 0 | ||
ObsEva SA (OBSV) | COM | H5861P103 | 2,884 | 1,386,338 | SH | SOLE | 1,386,338 | 0 | 0 | ||
POSEIDA THERAPEUTICS INC (PSTX) | COM | 73730P108 | 11,445 | 1,043,267 | SH | SOLE | 1,043,267 | 0 | 0 | ||
Sunesis Pharmaceuticals, Inc. (SNSS) | COM | 867328700 | 2,010 | 1,010,000 | SH | SOLE | 1,010,000 | 0 | 0 | ||
Verona Pharma plc (VRNA) | COM | 925050106 | 9,327 | 1,332,485 | SH | SOLE | 1,332,485 | 0 | 0 | ||
Zosano Pharma Corporation (ZSAN) | COM | 98979H202 | 1,433 | 2,718,226 | SH | SOLE | 2,718,226 | 0 | 0 | ||
Syndax Pharmaceuticals, Inc. (SNDX) | COM | 87164F105 | 22,796 | 1,025,000 | SH | SOLE | 1,025,000 | 0 | 0 | ||
Spruce Biosciences, Inc. (SPRB) | COM | 85209E109 | 29,306 | 1,205,511 | SH | SOLE | 1,205,511 | 0 | 0 |